Quantum Cyber N.V. (QUCY) stock: key figures, P/E, revenue and dividend
Health Care · Germany · ISIN NL0015000LC2
Quantum Cyber N.V. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 537,080.00 USD |
| Gross profit | 389,792.00 USD |
| Operating income | -16.14 m USD |
| EBIT | -15.84 m USD |
| Net income | -16.21 m USD |
| Diluted EPS – continuing operations | -2.70 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Quantum Cyber N.V.
Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Quantum Cyber N.V. was formerly known as Mainz Biomed N.V. and changed its name to Quantum Cyber N.V. in April 2026. The company is headquartered in Mainz, Germany.
More stocks
- Arlitech Electronic (6432.TWO)
- Gmb Korea (013870.KS)
- Litemax Electronics (4995.TWO)
- TRIO-TECH INTERNATIONAL (TRT)
- Andros Pharmaceuticals Co.,Ltd (6917.TWO)
- Big Sunshine Co Ltd (1475.TW)
- Daehan New Pharm Co. Ltd (054670.KQ)
- HAZER Group Ltd (HZR.AX)
- Hour Loop, Inc (HOUR)
- Daesung Hi-Tech Co. Ltd. (129920.KQ)
- Budi Starch & Sweetener Tbk (BUDI.JK)
- Beyond Securities PCL (BYD.BK)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.